Acquiring Acessa Health and its groundbreaking Acessa ProVu® system was an exciting milestone for Hologic that will enable us to further champion women’s health by expanding our portfolio to treat all stages of abnormal uterine bleeding and fibroids through a minimally invasive procedure. As we integrate the Acessa ProVu system into our surgical portfolio, we are excited to work closely with our customers and the passionate Acessa Health team to extend this solution to help more patients.
WHAT DOES THIS MEAN FOR YOU AND YOUR PATIENTS?
Comprehensive Treatment
With our full suite of products, including our NovaSure® and MyoSure® devices and now, the Acessa ProVu system, you will have the technology you need to treat a broader range of fibroids and address abnormal uterine bleeding, while performing procedures concomitantly.
Streamlined Experience
Hologic can now more seamlessly support your goal of meeting ever-changing patient needs by offering the best-inclass minimally invasive fibroid treatment approaches with supporting technology, medical education, and case support directly from one source.
Improved Patient Outcomes
The Acessa ProVu system offers a safe and effective alternative to hysterectomy and laparoscopic myomectomy, supported by clinical data demonstrating less blood loss and faster recovery times as compared to standard treatments currently available.1,2 The procedure also has a 94% patient satisfaction rate and 98% patient-to-patient recommendation rate, providing hope for patients with difficult to treat fibroids who are seeking a solution that will not require invasive surgery.3
1. SG Chudnoff, et al. Outpatient Procedure for the Treatment and Relief of Symptomatic Uterine Myomas. Obstetrics and Gynecology, 2013;121(5):1075-82
2. Bradley et al – RFA for Uterine fibroids Meta review – 2019
3. SG Chudnoff, et al. Outpatient Procedure for the Treatment and Relief of Symptomatic Uterine Myomas. Obstetrics and Gynecology, 2013;121(5):1075–82.